STOCK TITAN

OneMedNet Corp. - ONMD STOCK NEWS

Welcome to our dedicated news page for OneMedNet (Ticker: ONMD), a resource for investors and traders seeking the latest updates and insights on OneMedNet.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect OneMedNet's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of OneMedNet's position in the market.

Rhea-AI Summary
OneMedNet Corporation (ONMD) receives positive response at the 15th Annual SCOPE Summit for its regulatory-grade imaging Real World Data solutions. The company aims to collaborate with existing and new partners to enhance patient insight using iRWD.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.18%
Tags
clinical trial
-
Rhea-AI Summary
OneMedNet Corporation (ONMD) announces a growth initiative supporting women's health research, catering to increasing demand from Life Science innovators. The company has a vast regulatory-grade imaging Real World Data database, benefiting patients and organizations. With a focus on women's health issues like cancer, cardiac disease, and Alzheimer's, OneMedNet aims to provide dedicated resources for better understanding and opportunities in this sector.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.92%
Tags
none
-
Rhea-AI Summary
OneMedNet Corporation (Nasdaq: ONMD) will exhibit at the 15th Annual SCOPE Summit for Clinical Ops Executive to showcase its iRWD solution. The company's specialized Real World Data is curated with proprietary AI tools and will be discussed at the Real World Evidence track at the summit.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
168.1%
Tags
none
Rhea-AI Summary
OneMedNet Corporation (ONMD) announces a partnership with Beacon Health System, Inc. to promote new patient care diagnostic and treatment solutions using OneMedNet's iRWD™, reinforcing its leadership in Real World Data (RWD) for life science innovation. The partnership aims to provide critical new product decisions for life science organizations at every step of the innovation process, leveraging flawless data and the latest AI/ML technology. OneMedNet's iRWD network consists of over 235 healthcare systems and providers, including 150+ care sites treating 1.5m patients per year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.53%
Tags
none
-
Rhea-AI Summary
OneMedNet Corporation (ONMD) Expands Access to Regulatory-Grade Imaging Real World Data Platform Through AWS Data Exchange, Accelerating Life Sciences Innovation and Lowering Costs
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.29%
Tags
none
-
Rhea-AI Summary
OneMedNet Corporation (Nasdaq:ONMD) Announces Technical Exhibit at RSNA 2023 Annual Meeting
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.87%
Tags
AI
Rhea-AI Summary
OneMedNet Corporation (NASDAQ:ONMD) introduces its exclusive iRWD™ solution at ISPOR Europe 2023, the leading global conference for Health Economics and Outcomes Research (HEOR). The company's president and area vice president of sales will attend the event to engage with global healthcare leaders and discuss the latest trends in healthcare, emphasizing the value of real world data in medical research and diagnostics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.78%
Tags
conferences
-
Rhea-AI Summary
ONMD - OneMedNet Corporation Announces Partnership to Accelerate Life Science Innovation with Real World Data. The partnership aims to expand development of new diagnostic and treatment solutions using OneMedNet's iRWD, benefiting pharmaceutical, AI, medical device, and clinical research organizations. This collaboration will provide access to critical RWD for healthcare providers and Life Sciences, leveraging the expertise of over 200 healthcare systems and providers, including a top-ranked tertiary medical center with a leading cancer center.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.78%
Tags
partnership
OneMedNet Corp.

Nasdaq:ONMD

ONMD Rankings

ONMD Stock Data

21.61M
18.24M
19.02%
0.97%
4.85%
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Professional, Scientific, and Technical Services
Link
United States
Eden Prairie